A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Pfizer Takes the Lead in the Race to Develop a COVID-19 Vaccine


The American pharmaceutical company Pfizer reported that its COVID-19 vaccine is highly effective in preventing infection with the novel coronavirus in preliminary studies. In light of rising case numbers across the United States, this is particularly good news. The clinical trial determined that the vaccine was 90% effective in preventing COVID-19 and posed no safety risks to volunteers. The two-dose Pfizer vaccine is based on synthetic messenger RNA (mRNA), a new technology that helps the body’s own immune system identify and then combat the novel coronavirus by copying its surface. Read more here.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy